Blockchain Registration Transaction Record

Calidi Biotherapeutics to Host Investor Webinar Featuring New CMO and Oncolytic Virus Therapies

Calidi Biotherapeutics to host live investor webinar featuring new CMO and showcasing stem cell-based oncolytic virus therapies, including FDA-cleared products like CLD-201. Updates on programs for metastatic and lung cancer and high-grade gliomas will be provided, offering insights into potential breakthroughs in cancer treatment technology.

This news matters as it highlights the advancements in cancer treatment technology by Calidi Biotherapeutics, offering potential breakthroughs for various oncology indications. The live webinar provides a unique opportunity for investors and the public to learn about the company's innovative stem cell-based platforms and the progress of its clinical stage products.